Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-11-10
2022-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SET-HIGH
High volume speed endurance training
Training
6 weeks of training
Formoterol
inhalation of 54 microg formoterol
Placebo
inhalation of placebo
SET-LOW
Low volume speed endurance training
Training
6 weeks of training
Formoterol
inhalation of 54 microg formoterol
Placebo
inhalation of placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training
6 weeks of training
Formoterol
inhalation of 54 microg formoterol
Placebo
inhalation of placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Trained individuals with a maximal oxygen uptake above 55 ml/min/kg
* Body mass index lower than 26
Exclusion Criteria
* Unacceptable side effects to the study drug
* Chronic disease deemed by the MD to interfere with the study
* Smoking
* Use of prescription medicine
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Hostrup, PhD
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOREX
Identifier Type: -
Identifier Source: org_study_id